Pipeline

Bi-specific antibody

Project Code Molecule Type Target Indication Development

YBL-004

Naked & Bispecific Antibody

TNF-α & IL-17a

Autoimmune Disease

Preclinical

YBL-008

Bispecific Antibodies

PD-L1 & VEGF-α

Immuno-oncology

Early Discovery

YBL-009

Bispecific Antibodies

PD-L1 & TGF-β

Immuno-oncology

Early Discovery

YBL-013

BsAb (ALiCE)

PD-:L1 & CD3

Immuno-oncology

Cell Line

YBL-016

BsAb

PD-L1 & IL10

Immuno-oncology

Late Discovery

YBL-017

BsAb (ALiCE)

DLK-1 & CD3

Immuno-oncology

Late Stage

YBL-018

BsAb (ALiCE)

B7-H3 & CD3

Immuno-oncology

Late Discovery

YBL-019

BsAb

PD-1 & LAG-3

Immuno-oncology

Cell Line

YBL-020

BsAb

PD-L1 & LAG-3

Immuno-oncology

Cell Line

YBL-031

BsAb (ALiCE)

CD20 & CD3

Immuno-oncology

Late Discovery

YBL-032

BsAb (ALiCE)

EGFR & CD3

Immuno-oncology

Late Discovery